Effects of combination therapy with olmesartan and azelnidipine on serum osteoprotegerin in patients with hypertension

Journal of Cardiovascular Pharmacology and Therapeutics

Volumn 19, Issue 3, 2014, Pages 304-309

  Uzui, Hiroyasu ^a   Morishita, Tetsuji ^a   Nakano, Akira ^a   Amaya, Naoki ^a   Fukuoka, Yoshitomo ^a   Ishida, Kentaro ^a   Arakawa, Kenichiro ^a   Lee, Jong Dae ^a   Tada, Hiroshi ^a  

^a UNIVERSITY OF FUKUI   (Japan)

Author keywords

arterial stiffness; azelnidipine; hypertension; olmesartan; osteoprotegerin

Indexed keywords

AZELNIDIPINE; C REACTIVE PROTEIN; CREATININE; GELATINASE A; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INDAPAMIDE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OLMESARTAN; OSTEOPROTEGERIN; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; AZETIDINE 2 CARBOXYLIC ACID; BIOLOGICAL MARKER; CALCIUM CHANNEL BLOCKING AGENT; DIHYDROPYRIDINE DERIVATIVE; DIURETIC AGENT; HYDROCHLOROTHIAZIDE; IMIDAZOLE DERIVATIVE; TETRAZOLE DERIVATIVE;

ADULT; AGED; ARTERIAL STIFFNESS; ARTICLE; BODY MASS; CARDIO ANKLE VASCULAR INDEX; CARDIOVASCULAR PARAMETERS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; ESSENTIAL HYPERTENSION; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; HYPERLIPIDEMIA; MALE; OPEN STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULSE RATE; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; ANALOGS AND DERIVATIVES; BLOOD PRESSURE; DRUG COMBINATION; DRUG EFFECTS; HYPERTENSION; METABOLISM; MIDDLE AGED; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANTIHYPERTENSIVE AGENTS; AZETIDINECARBOXYLIC ACID; BIOLOGICAL MARKERS; BLOOD PRESSURE; C-REACTIVE PROTEIN; CALCIUM CHANNEL BLOCKERS; DIHYDROPYRIDINES; DIURETICS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HYDROCHLOROTHIAZIDE; HYPERTENSION; IMIDAZOLES; MALE; MATRIX METALLOPROTEINASE 2; MIDDLE AGED; OSTEOPROTEGERIN; PROSPECTIVE STUDIES; TETRAZOLES;

EID: 84898987994     PISSN: 10742484     EISSN: 19404034     Source Type: Journal    
DOI: 10.1177/1074248413511692     Document Type: Article

References (23)

1. Doherty TM, Uzui H, Fitzpatrick LA, et al. Rationale for the role of osteoclast-like cells in arterial calcification. FASEB J. 2002 ; 16 (6). 577-582
2. Shao JS, Cheng SL, Sadhu J, Towler DA. Inflammation and the osteogenic regulation of vascular calcification a review and perspective. Hypertension. 2010 ; 55 (3). 579-592
3. Hosbond SE, Poulsen TS, Diederichsen AC, Nybo M, Rasmussen LM, Mickley H. Osteoprotegerin as a marker of atherosclerosis: a systematic update. Scand Cardiovasc J. 2012 ; 46 (4). 203-211
4. Wellington K, Scott LJ. Azelnidipine. Drugs. 2003 ; 63 (23). 2613-2621
5. Robinson DM, Wellington K. Indapamide sustained release: a review of its use in the treatment of hypertension. Drugs. 2006 ; 66 (2). 257-271
6. Kuramoto K, Ichikawa S, Hirai A, Kanada S, Nakachi T, Ogihara T. Azelnidipine and amlodipine: a comparison of their pharmacokinetics and effects on ambulatory blood pressure. Hypertens Res. 2003 ; 26 (3). 201-208
7. Jamerson K, Weber MA, Bakris GL, et al. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med. 2008 ; 359 (23). 2417-2428
8. Patel A, MacMahon S, Chalmers J, et al. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. Lancet. 2007 ; 370 (9590). 829-840
9. Nakamura U, Iwase M, Nohara S, Kanai H, Ichikawa K, Iida M. Usefulness of brachial-ankle pulse wave velocity measurement: correlation with abdominal aortic calcification. Hypertens Res. 2003 ; 26 (2). 163-167
10. Mitsutake R, Miura S, Saku K. Association between coronary artery calcification score as assessed by multi-detector row computed tomography and upstroke time of pulse wave. Intern Med. 2007 ; 46 (22). 1833-1836
11. Mogelvang R, Pedersen SH, Flyvbjerg A, et al. Comparison of osteoprotegerin to traditional atherosclerotic risk factors and high-sensitivity C-reactive protein for diagnosis of atherosclerosis. Am J Cardiol. 2012 ; 109 (4). 515-520
12. Jung CH, Lee WY, Kim SY, et al. The relationship between coronary artery calcification score, plasma osteoprotegerin level and arterial stiffness in asymptomatic type 2 DM. Acta Diabetol. 2010 ; 47 (suppl 1). S145 - S152
13. Park JS, Cho MH, Nam JS, et al. Effect of pioglitazone on serum concentrations of osteoprotegerin in patients with type 2 diabetes mellitus. Eur J Endocrinol. 2011 ; 164 (1). 69-74
14. Son BK, Kozaki K, Iijima K, et al. Statins protect human aortic smooth muscle cells from inorganic phosphate-induced calcification by restoring Gas6-Axl survival pathway. Circ Res. 2006 ; 98 (8). 1024-1031
15. Yamagishi S, Inagaki Y, Nakamura K, Imaizumi T. Azelnidipine, a newly developed long-acting calcium antagonist, inhibits tumor necrosis factor-alpha-induced interleukin-8 expression in endothelial cells through its anti-oxidative properties. J Cardiovasc Pharmacol. 2004 ; 43 (5). 724-730
16. Miyashita Y, Saiki A, Endo K, et al. Effects of olmesartan, an angiotensin II receptor blocker, and amlodipine, a calcium channel blocker, on cardio-ankle vascular index (CAVI) in type 2 diabetic patients with hypertension. J Atheroscler Thromb. 2009 ; 16 (5). 621-626
17. Bokuda K, Ichihara A, Sakoda M, Mito A, Kinouchi K, Itoh H. Blood pressure-independent effect of candesartan on cardio-ankle vascular index in hypertensive patients with metabolic syndrome. Vasc Health Risk Manag. 2010 ; 6: 571-578
18. Miyashita Y, Endo K, Saiki A, et al. Effects of pitavastatin, a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, on cardio-ankle vascular index in type 2 diabetic patients. J Atheroscler Thromb. 2009 ; 16 (5). 539-545
19. Winer N, Folker A, Murphy JA, et al. Effect of fixed-dose ACE-inhibitor/calcium channel blocker combination therapy vs. ACE-inhibitor monotherapy on arterial compliance in hypertensive patients with type 2 diabetes. Prev Cardiol. 2005 ; 8 (2). 87-92
20. Siragy HM, Xue C, Webb RL. Beneficial effects of combined benazepril-amiodipine on cardiac nitric oxide, cGMP, and TNF-alpha production after cardiac ischemia. J Cardiovasc Pharmacol. 2006 ; 47 (5). 636-642
21. Ogawa S, Mori T, Nako K, Ito S. Combination therapy with renin-angiotensin system inhibitors and the calcium channel blocker azelnidipine decreases plasma inflammatory markers and urinary oxidative stress markers in patients with diabetic nephropathy. Hypertens Res. 2008 ; 31 (6). 1147-1155
22. Zhou MS, Schulman IH, Jaimes EA, Raij L. Thiazide diuretics, endothelial function, and vascular oxidative stress. J Hypertens. 2008 ; 26 (3). 494-500
23. Matsui Y, Eguchi K, O'Rourke MF, et al. Differential effects between a calcium channel blocker and a diuretic when used in combination with angiotensin II receptor blocker on central aortic pressure in hypertensive patients. Hypertension. 2009 ; 54 (4). 716-762